Skip to main content
. 2025 Aug 15;104(33):e43686. doi: 10.1097/MD.0000000000043686

Table 1.

Management and mechanisms of KOA.

Management of KOA Mechanisms of KOA
Pharmaceutical approaches Non-pharmaceutical approaches Surgical management Pathogenesis Molecular mechanisms of KOA
NSAIDS Health education OAK Excessive proliferation of chondrocytes MMPs, ADAMTS↑
Analgesics Regular exercise including aerobic, strengthening, and resistance exercises UKA Abundance of ECM IL-1β, IL-6, TNF-α↑
Glucocorticoids Weight loss TKA Synovial inflammation NF-κB, MAPK, PI3K/Akt signaling pathway
Targeted therapy strategies Physical therapy including therapeutic ultrasound, electrical stimulation, phototherapy, hydrotherapy, magnet therapy, acupuncture and moxibustion Breakdown of cartilage tissue

ADAMTS = a disintegrin and metalloproteinase with thrombospondin motifs, ECM = extracellular matrix, IL-1β = interleukin-1, IL-6 = interleukin-6, KOA = knee osteoarthritis, MMPs = matrix metalloproteinases, NSAIDs = nonsteroidal anti-inflammatory drugs, OAK = osteotomy around the knee, TKA = total knee arthroplasty, TNF-α = tumor necrosis factor-alpha, UKA = uknee arthroplasty.